Ligand validation:7VIC

ODN: (1beta,6beta,7beta,8alpha,9beta,10alpha,13alpha,14R,16beta)-1,6,7,14-tetrahydroxy-7,20-epoxykauran-15-one

ODN is a Ligand Of Interest in 7VIC designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7VIC_ODN_A_401	2%	62%	0.294	0.573	0.43	1	-	3	7	0	100%	1
8H6I_ODN_A_401	26%	66%	0.188	0.828	0.42	0.87	-	1	0	0	100%	1
6M6X_ODN_C_1106	67%	26%	0.131	0.94	1.14	1.83	3	9	1	0	100%	1
7N3K_ODN_D_201	62%	28%	0.178	0.972	1.11	1.74	2	9	0	0	100%	1
4PE7_ODN_A_101	26%	34%	0.178	0.82	1.06	1.55	2	3	0	0	100%	1
7DKM_ODN_A_401	12%	36%	0.266	0.8	1.08	1.44	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.